Related Experiment Video
Updated: May 20, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Percutaneous interstitial brachytherapy for adrenal metastasis: technical report
Kazushi Kishi1, Shinji Tamura, Yasushi Mabuchi
1Department of Radiation Oncology, Wakayama Medical University, Wakayama City, 641-8510 Japan. kazushi.kishi@gmail.com
We developed a new interstitial brachytherapy technique for adrenal metastasis. This outpatient procedure is safe and effective, offering a potential new treatment option for patients with adrenal tumors.
Area of Science:
- Interventional Radiology
- Oncology
- Radiation Oncology
Background:
- Adrenal metastasis presents a significant clinical challenge.
- Existing treatments for adrenal metastasis may have limitations.
Observation:
- A novel interstitial brachytherapy technique was adapted from radiofrequency ablation.
- The procedure was performed on an outpatient basis under local anesthesia and CT guidance.
- Treatment plans prioritized tumor eradication while preserving adjacent organs.
Findings:
- Two patients with adrenal metastasis (uterine cervical cancer, malignant melanoma) were successfully treated.
- The procedure took 2.5 hours with no immediate or delayed complications.
- FDG PET-CT scans showed no uptake post-treatment, indicating tumor eradication.
- No adrenal tumor recurrence was observed for over six months in both cases.
Implications:
- This interventional brachytherapy shows promise as a safe and effective treatment for adrenal metastasis.
- Outpatient brachytherapy offers a potentially less invasive option for managing adrenal tumors.
- Further studies are warranted to confirm the long-term efficacy and applicability of this technique.
More Related Videos
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018